Leah Kuntz

Donanemab for the treatment of Alzheimer disease has received Breakthrough Therapy designation from the FDA.

For the first time since 2015, Scottish Parliament is considering legislation on medical aid in dying.

The 2021 American Psychiatric Association Virtual Annual Meeting brought together leaders in psychiatry to discuss hot topics including diversity, COVID-19, mood disorders, and more.

According to a recent study, COVID-19 vaccines did not impact sperm parameters.

Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.

Genes may hold the answer to the puzzling comorbidity of migraines and posttraumatic stress disorder.

These deals can help boost you and your patients’ mental health.

Zuranolone showed statistically significant improvement in depressive symptoms in this latest study.

This renowned psychiatrist is donating a portion of the proceeds from his book sales to help stop US military veteran suicides.

The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.

What impact has the pandemic had on children's mental health?

Have you gotten your COVID-19 vaccine?

This is a rare opportunity for researchers and entrepreneurs from a variety of fields to conduct experiments in space.

June is posttraumatic stress disorder (PTSD) Awareness Month!

This one-of-a-kind Alzheimer disease treatment targets the amyloid beta plaques in the brain, potentially slowing cognitive decline.

This combination treatment of olanzapine and samidorphan caused significantly less weight gain in patients with schizophrenia and bipolar I disorder.

What terms are used to describe SGM and LGBTQ+ identities?

Over a third of older Americans aren't comfortable taking off their masks until 2022.

This treatment for agitation associated with schizophrenia and bipolar disorder is moving up the FDA ladder…

Two posters presented at the APA virtual meeting demonstrated long-acting injectable positive results, costs savings, and increased telehealth for patients with schizophrenia.

Finding a program that is a good fit while LGBTQ+ may be more difficult than it seems…

Young, professional women in academic psychiatry are facing down the iceberg: gender discrimination.

According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?

Data presented at the 2021 APA Virtual Annual Meeting show promise for treating schizophrenia.

Can depression be passed on to future generations, and if it can, how can treatment help?

One doctor at the APA Virtual meeting explains how ketamine can rebuild spine and synaptic proteins in the brain, but may be difficult to actually prescribe to patients.

The FDA approved a higher dose of naloxone to treat opioid overdose deaths.

The Drug Enforcement Administration has freed this formerly schedule II controlled substance.

Looking to reduce youth initiation into tobacco products, the FDA takes steps against menthol cigarettes and flavored cigars.

The FDA cleared the way to use this deep transcranial magnetic stimulation system, which may be able to help treat depression in less than 5 minutes.